Jen L, PhD's Avatar

Jen L, PhD

@drjkyl.bsky.social

Executive Editor/Team Lead Open Access Science & Medicine Journals Sage Publishing Opinions = mine http://linkedin.com/in/jlovick-editor #oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare

3,040 Followers  |  16,787 Following  |  341 Posts  |  Joined: 17.02.2025
Posts Following

Posts by Jen L, PhD (@drjkyl.bsky.social)

Post image

Analysis of 346 BCBM cases from the GEICAM RegistEM registry reveals faster CNS progression and poorer survival in TNBC and HER2+ subtypes, with major differences between de novo vs subsequent brain metastases.
πŸ”— buff.ly/74yHwuH
#BreastCancer #BrainMets #HER2 #TNBC #RealWorldEvidence

28.02.2026 08:15 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

A rev in Ther Adv Med Onc highlights the unique challenges of early breast cancer in young BRCA carriers-covering surveillance, risk‑reducing surgery, PARP‑based therapy, fertility considerations, and survivorship needs. πŸ”—https://buff.ly/6fj4pvT
#BreastCancer #BRCA #Oncology #YoungPatients

28.02.2026 16:31 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

Safety and Efficacy of CT-Guided Lung Biopsy in Elderly Patients age 75 Years and Older: A Single-Centre Retrospective Comparative Study
@tcrtcancer.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#lungcancer #diagnostics #oncology #cancerresearch #openaccess

27.02.2026 19:58 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Comprehensive versus thrombectomy-capable stroke centers: a web-based model to predict outcomes after mechanical thrombectomy - Shujuan Gan, Weifeng Huang, Tingyu Yi, Wenli Zhang, Xiongwei Lu, Zhiting... Background: The quality and clinical outcomes of mechanical thrombectomy (MT) performed at thrombectomy-capable stroke centers (TSCs) versus comprehensive strok...

New research online!
When patients undergo mechanical thrombectomy, does being treated in a thrombectomy-capable versus comprehensive #stroke center affect the outcomes?
Find out more here: journals.sagepub.com/doi/full/10....

27.02.2026 11:22 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Does noninvasive ventilation during pulmonary rehabilitation help improve patient outcomes? Read our latest article to find out!

journals.sagepub.com/doi/10.1177/...

27.02.2026 15:14 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

πŸ“„New research online!

πŸ’ŠWhat is the real-world effectiveness of #cladribine tablets in people with #MultipleSclerosis?

πŸ‘¨β€βš•οΈMatteo Lucchini and colleagues analyzed data from multiple centers in Italy:
journals.sagepub.com/doi/full/10....

26.02.2026 09:16 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

Top Read Papers on Natural Product Communications - February 2026

πŸ’‘4. Chemical Constituents and Antimicrobial Activity of the Halophyte Atriplex leucoclada

journals.sagepub.com/doi/10.1177/...

26.02.2026 09:40 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

New online!
Here, Bhupendra Khatri and colleagues discuss their experiences in therapeutic plasma exchange in autoimmune neurological disorders: journals.sagepub.com/doi/full/10....

24.02.2026 11:57 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

New review - The treatment landscape for advanced gastric/GEJ adenocarcinoma is rapidly evolving. Upfront ICIs, targeted agents, and biomarker‑guided strategies are reshaping first‑line, maintenance, and sequential therapy.
πŸ”— buff.ly/22B0Oz0
#GastricCancer #GEJ #Immunotherapy #TargetedTherapy

25.02.2026 08:15 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

A review in Ther Adv Med Onc summarizes major advances in SCLC: chemo‑IO as standard in ES‑SCLC, durvalumab approved for LS‑SCLC, emerging options for relapse (lurbinectedin, tarlatamab), and evolving biomarkers/transcriptional subtypes. πŸ”—https://buff.ly/LoHtjYT
#SCLC #LungCancer #Immunotherapy

25.02.2026 16:30 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Temporal dynamics of mesenchymal stem cell administration influence immune modulation in a 4T1 breast cancer model
doi.org/10.1177/0963...
#MSCs #CancerTreatment
@journals.sagepub.com

23.02.2026 10:30 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

Cellular replacement therapy for diabetes
doi.org/10.1177/0963...
#diabetes
@journals.sagepub.com

23.02.2026 10:31 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

Incidence and clinical relevance of donor-derived recipient-specific anti-HLA antibodies in haploidentical hematopoietic stem cell transplantation: a retrospective study
doi.org/10.1177/0963...

23.02.2026 10:34 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Allogeneic hematopoietic stem cell transplantation for the treatment of chronic active Epstein–Barr virus infection
doi.org/10.1177/0963...
#stemcell #transplantation #virus
@journals.sagepub.com

23.02.2026 10:36 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

New research online! πŸ“°
Is horizontal switching a valid #MultipleSclerosis treatment strategy?

Enrique Gomez-Figueroa and colleagues analyzed the MSBase Registry to find out the real-world effectiveness of horizontal switching between disease-modifying therapies:
journals.sagepub.com/doi/full/10....

23.02.2026 12:01 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

Strongyloides hyperinfection can occur without eosinophiliaβ€”even with CD4 >500 and undetectable HIV viral load. Early diagnosis is lifesaving ⚠️
journals.sagepub.com/doi/full/10....

21.02.2026 13:20 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Real‑world evidence in Ther Adv Med Onc shows nal‑IRI/5‑FU/LV significantly improves OS in pancreatic adenocarcinoma (28.0 vs 18.3 months) despite higher cost (ICER $33,285/LYG). πŸ”—https://buff.ly/dOq2XvY
#PancreaticCancer #GIOnc #RealWorldEvidence #HealthEconomics

21.02.2026 16:30 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Thank you for featuring this important research published in @tcrtcancer.bsky.social!

@apploniarose.bsky.social
@journals.sagepub.com

#oncology #cancerresearch #lymphoma #openaccess

20.02.2026 23:23 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

New online!
This large (>20000 patients) cohort study on secondary #stroke prevention describes the challenges in adherence to secondary stroke prevention medication in China:
journals.sagepub.com/doi/full/10....
#MedSky #NeuroSky

20.02.2026 10:19 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

French consensus published in Ther Adv Med Onc-provide practical, real‑world guidance to prevent and manage hematologic toxicities from PARPis in metastatic PC-an area of growing need.
πŸ”— Full article: buff.ly/9fa08rG
#ProstateCancer #mCRPC #PARPInhibitors #Oncology

18.02.2026 18:04 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Post image

A new multicenter Chinese study in Ther Adv Med Onc evaluated PARPi in metastatic #breastcancer with HRR gene pathogenic variants.
mPFS reached 6.0 months, with consistent benefit across BRCA1/2, PALB2 and other HRR mutations.
πŸ”— buff.ly/x4JnB05
#MBC #PARP #HRR

18.02.2026 08:15 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 1    πŸ“Œ 0
Post image

Happy Lunar New Year’s Eve! πŸŽ‡
Welcoming the Year of the Horse with gratitude for a year working alongside the global oncology community through Therapeutic Advances in Medical Oncology and Sage Oncology journals.
Wishing everyone health, energy, and new breakthroughs in the year ahead. 🐎✨ 马年倧吉!

16.02.2026 08:15 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Preview
Regional perfusion parameters as potential indicators of parenchymal hematoma risk following reperfusion therapy for acute ischemic stroke in the extended time window - Xinyu Liu, Lan Hong, Guangjian ... Background: Parenchymal hematoma (PH) is a common complication of acute ischemic stroke, particularly following reperfusion therapy. Objective: This study aime...

New article out in our Special Collection on Acute Reperfusion Therapies for Acute Ischemic Stroke:

Is there a relationship between regional perfusion parameters and parenchymal hematoma outcomes in #stroke patients treated in the extended time window?
journals.sagepub.com/doi/full/10....

16.02.2026 10:55 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

πŸ“ New #SystematicReview & Meta-Analysis online!

🧠 What is the safety and efficacy of initiating oral anticoagulants versus avoiding anticoagulation in adults with #AFib after spontaneous intracranial hemorrhage?

πŸ—‚οΈ This article draws evidence from #stroke RCTs:
journals.sagepub.com/doi/full/10....

17.02.2026 13:44 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Introduction - I lead a team of amazing PhD Managing Editors that support @journals.sagepub.com 's Open Access Clinical Journals. I share articles from our journals that I find interesting. Happy to connect with researchers! Also on LinkedIn and ResearchGate. πŸ“–πŸ”¬πŸ§ͺπŸ’Š #medicine #oncology #neuro #cardio

15.02.2026 05:42 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
Sage Journals: Discover world-class research Subscription and open access journals from Sage, the world's leading independent academic publisher.

Invasive pulmonary aspergillosis remains a lethal threat in immunocompromised and post-COVID patients 🦠 Advances in PCR, lateral flow assays, and immuno-PET/MRI are reshaping diagnosis, but rising azole resistance demands susceptibility testing
journals.sagepub.com/doi/full/10....

14.02.2026 14:11 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

ctDNA findings from the Ni‑High phase Ib trial: ERBB2 focal amplification and early mMAF decline strongly predict improved outcomes with trastuzumab + nivolumab + chemo in HER2+ aGC.
πŸ”—https://buff.ly/S2kBuFe
#GastricCancer #HER2 #ctDNA

14.02.2026 18:04 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

New review highlights how PSMA‑targeted radioligand therapy, including 177Lu‑PSMA‑617 and emerging isotopes like 225Ac/161Tb, is reshaping advanced prostate cancer care. Combination strategies and precision dosimetry point to a rapidly evolving future.
πŸ”— buff.ly/WKhPij0
#ProstateCancer #RLT #PSMA

13.02.2026 08:15 β€” πŸ‘ 1    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

From schizophrenia to dementia: Is Cobenfy a potential treatment for behavioral and psychological symptoms of dementia?

Journal of International Medical Research
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#neuropsychiatric #pharmacology #medicine #research #openaccess

12.02.2026 21:38 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

Clinical efficacy and safety of endoscopic ultrasound-guided ablation therapies for pancreatic neuroendocrine tumors: a systematic review and meta-analysis
@tagastroenterol.bsky.social
@journals.sagepub.com

journals.sagepub.com/doi/10.1177/...

#pancreaticcancer #raretumors #oncology #openaccess

12.02.2026 21:36 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0